UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$205M |
| 2 |
Johnson & Johnson
JNJ
|
+$186M |
| 3 |
Honeywell
HON
|
+$177M |
| 4 |
Mondelez International
MDLZ
|
+$132M |
| 5 |
Alibaba
BABA
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$270M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$212M |
| 3 |
Citigroup
C
|
+$185M |
| 4 |
Booking.com
BKNG
|
+$104M |
| 5 |
Intuitive Surgical
ISRG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 14.47% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Mettler-Toledo International
MTD
$28.6B
| $27M | 0.03% |
73,974
+11,789
| +19% | +$4.31M |
|
527
Oneok
OKE
$57.2B
| $26.9M | 0.03% |
566,820
+16,701
| +3% | +$663K |
|
528
Mohawk Industries
MHK
$7.5B
| $26.9M | 0.03% |
141,500
+3,096
| +2% | +$603K |
|
|
XEC
529
DELISTED
CIMAREX ENERGY CO
XEC
| $26.8M | 0.03% |
224,603
-3,886
| -2% | -$435K |
|
|
QVCGA
530
DELISTED
QVC Group Inc Series A
QVCGA
| $26.8M | 0.03% |
21,744
+58
| +0.3% | +$72.9K |
|
531
CGI
GIB
$15.1B
| $26.7M | 0.03% |
628,435
+10,472
| +2% | +$484K |
|
532
Maximus
MMS
$3.17B
| $26.6M | 0.03% |
480,963
+1,193
| +0.2% | +$64.3K |
|
533
Cenovus Energy
CVE
$55.7B
| $26.5M | 0.03% |
1,929,184
+61,567
| +3% | +$891K |
|
|
LLL
534
DELISTED
L3 Technologies, Inc.
LLL
| $26.3M | 0.03% |
179,431
-789
| -0.4% | -$106K |
|
535
Voya Financial
VOYA
$9.01B
| $26.3M | 0.03% |
1,060,939
-1,979,995
| -65% | -$60.6M |
|
536
United Therapeutics
UTHR
$25.8B
| $26.1M | 0.03% |
246,563
+20,278
| +9% | +$2.26M |
|
|
AGU
537
DELISTED
Agrium
AGU
| $26.1M | 0.03% |
289,873
+1,352
| +0.5% | +$120K |
|
538
Eastman Chemical
EMN
$8B
| $26M | 0.03% |
383,288
+7,493
| +2% | +$551K |
|
539
Alliant Energy
LNT
$18.3B
| $26M | 0.03% |
655,506
+6,704
| +1% | +$249K |
|
540
Telus
TU
$14.9B
| $26M | 0.03% |
1,622,516
+46,914
| +3% | +$743K |
|
541
Atara Biotherapeutics
ATRA
$75.5M
| $25.9M | 0.03% |
46,107
-2,519
| -5% | -$1.21M |
|
542
AES
AES
$10.5B
| $25.9M | 0.03% |
2,076,807
-9,637
| -0.5% | -$109K |
|
|
GIMO
543
DELISTED
Gigamon Inc.
GIMO
| $25.8M | 0.03% |
690,458
+164,426
| +31% | +$5.24M |
|
544
Broadridge
BR
$17.8B
| $25.7M | 0.03% |
394,125
+261,280
| +197% | +$16.2M |
|
|
PNRA
545
DELISTED
Panera Bread Co
PNRA
| $25.7M | 0.03% |
121,188
-4,188
| -3% | -$892K |
|
546
Palo Alto Networks
PANW
$270B
| $25.6M | 0.03% |
1,253,916
+106,764
| +9% | +$2.47M |
|
|
HTWR
547
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $25.5M | 0.03% |
441,908
-376,313
| -46% | -$12.3M |
|
548
Trip.com Group
TCOM
$29.6B
| $25.3M | 0.03% |
613,505
+376,753
| +159% | +$16.4M |
|
549
DexCom
DXCM
$31.5B
| $25.3M | 0.03% |
1,273,848
+375,516
| +42% | +$6.39M |
|
550
Akamai
AKAM
$16.7B
| $25.3M | 0.03% |
451,531
+3,351
| +0.7% | +$176K |
|
Similar funds
UBS AM's Q2 2016 Portfolio in Review
As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
- UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
- UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
- UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
- UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
- UBS AM opened 65 new positions and closed 89 in Q2 2016.
- UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.